These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1799954)

  • 1. Synthesis of the 2',3'-dideoxynucleoside derivatives of the specific binding peptide part of CD4.
    Uchiyama T; Yoshino H; Takemoto M; Achiwa K
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):3091-3. PubMed ID: 1799954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of the 2',3'-dideoxynucleoside derivatives of the specific binding peptide part of CD4.
    Uchiyama T; Yoshino H; Takemoto M; Achiwa K
    Nucleic Acids Symp Ser; 1991; (25):189-90. PubMed ID: 1842077
    [No Abstract]   [Full Text] [Related]  

  • 3. A biochemical approach for detecting interactions between peptides from the HIV gp120 glycoprotein and a CD4 sequence.
    Chersi A; Falasca G; Malorni W
    Z Naturforsch C J Biosci; 2004; 59(9-10):734-8. PubMed ID: 15540608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
    Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of the interaction between peptide T and CD4 using surface plasmon resonance.
    Ramsdale TE; Andrews PR; Nice EC
    FEBS Lett; 1993 Nov; 333(3):217-22. PubMed ID: 8224182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and interactions of CD4.
    Harrison SC; Wang J; Yan Y; Garrett T; Liu J; Moebius U; Reinherz E
    Cold Spring Harb Symp Quant Biol; 1992; 57():541-8. PubMed ID: 1339691
    [No Abstract]   [Full Text] [Related]  

  • 9. The design of a specific ligand of HIV gp120.
    Scarselli M; Facchiano A; Russo G; Molinari H; Ragona L; Zetta L; Niccolai N
    J Pept Sci; 1997; 3(5):383-90. PubMed ID: 9391913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
    Berger EA; Lifson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.
    Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL
    J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro. Implications for the design of small peptide anti-HIV therapeutic agents.
    Rausch DM; Hwang KM; Padgett M; Voltz AH; Rivas A; Engleman E; Gaston I; McGrath M; Fraser B; Kalyanaraman VS
    Ann N Y Acad Sci; 1990; 616():125-48. PubMed ID: 2078014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
    Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis.
    Hager-Braun C; Tomer KB
    Biochemistry; 2002 Feb; 41(6):1759-66. PubMed ID: 11827520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conformational switch is associated with receptor affinity in peptides derived from the CD4-binding domain of gp120 from HIV I.
    Reed J; Kinzel V
    Biochemistry; 1991 May; 30(18):4521-8. PubMed ID: 2021643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine binding.
    Howie SE; Fernandes ML; Heslop I; Hewson TJ; Cotton GJ; Moore MJ; Innes D; Ramage R; Harrison DJ
    FASEB J; 1999 Mar; 13(3):503-11. PubMed ID: 10064617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
    FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The envelope glycoprotein of HIV-1 may have incorporated the CD4 binding site from HLA-DQ beta 1.
    Brinkworth RI
    Life Sci; 1989; 45(20):iii-ix. PubMed ID: 2557504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic peptides representing discontinuous CD4 binding epitopes of HIV-1 gp120 that induce T cell apoptosis and block cell death induced by gp120.
    Howie SE; Cotton GJ; Heslop I; Martin NJ; Harrison DJ; Ramage R
    FASEB J; 1998 Aug; 12(11):991-8. PubMed ID: 9707171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.
    Autiero M; Houlgatte R; Martin M; Auffray C; Guardiola J; Piatier-Tonneau D
    Int Immunol; 1995 Feb; 7(2):191-7. PubMed ID: 7734415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.